U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931223) titled 'Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia' on March 31.
Brief Summary: The use of Neuromodulators is now recognized by international consensus as effective in improving Disorders of Gut-Brain Interaction (DGBIs). However, the digestive mind-body concept of therapeutic drugs is still in the experience-based treatment stage, and there is a lack of clinical studies in the field of DGBIs. Although numerous studies have been conducted to confirm the safety of Neuromodulators for the treatment of DGBIs, the current functional dyspepsia (FD) treatment is still awaiting further explorations and accumulations. In additi...